2021
DOI: 10.1007/s00253-020-11028-6
|View full text |Cite
|
Sign up to set email alerts
|

Progress of cationic gene delivery reagents for non-viral vector

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
20
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(23 citation statements)
references
References 90 publications
0
20
0
Order By: Relevance
“…In particular, synthetic or natural cationic polymers [ 7 , 8 ] containing primary, secondary, and/or tertiary amine groups can electrostatically bind and condense nucleic acids in the form of nanoscaled polyplexes [ 1 , 6 , 9 ]. The polyplex formation is an entropy-driven process based on ionic interaction between the cationic amino groups and the negatively charged phosphate groups of polyanionic nucleic acids [ 6 , 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…In particular, synthetic or natural cationic polymers [ 7 , 8 ] containing primary, secondary, and/or tertiary amine groups can electrostatically bind and condense nucleic acids in the form of nanoscaled polyplexes [ 1 , 6 , 9 ]. The polyplex formation is an entropy-driven process based on ionic interaction between the cationic amino groups and the negatively charged phosphate groups of polyanionic nucleic acids [ 6 , 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…24 Viral vectors are restricted in clinical applications due to their safety issues. Non-viral vectors, which have been widely developed and adopted due to their low virulence and non-immunogenicity, [25][26][27] include cationic liposomes, 28 polyethyleneimine (PEI) 29 and poly (β-amino ester) (PBAE). 30,31 Among non-viral vectors, PBAEs are a widely used type of cationic polymer gene carrier with excellent biocompatibility, good biodegradability, easy production, and low cost.…”
Section: Introductionmentioning
confidence: 99%
“…Compared with common RNA DC vaccines, nanocarriers delivering tumor antigen RNA possess several advantages: (1) Avoiding the complex procedure of isolation of DCs; (2) Nanocarriers can effectively increase the stability of RNA; (3) Nanocarriers are more readily recognized and engulfed by DCs compared with free drugs. Cationic liposomes are one of the most studied carriers in gene therapy (Ma et al, 2021). We have previously successfully developed PEGylated liposome-polycation DNA complex (LPD) for siRNA and RNA delivery (Gao et al, 2011(Gao et al, , 2012(Gao et al, , 2013.…”
Section: Introductionmentioning
confidence: 99%